Pharma-Bio Serv, Inc.
PBSV
$0.60
-$0.09-13.03%
OTC PK
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -84.30K | -189.20K | -498.40K | -777.60K | -840.80K |
| Total Depreciation and Amortization | 216.40K | 202.50K | 186.40K | 181.20K | 179.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -116.50K | -100.00K | -158.00K | -198.30K | -378.30K |
| Change in Net Operating Assets | -431.90K | -1.24M | -1.25M | 228.00K | 702.80K |
| Cash from Operations | -416.20K | -1.32M | -1.72M | -566.70K | -336.70K |
| Capital Expenditure | -163.30K | -163.20K | -158.90K | -159.70K | -1.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -275.00K | 1.79M | 4.55M | -1.20M | 5.80M |
| Cash from Investing | -438.20K | 1.62M | 4.39M | -1.36M | 5.79M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -22.20K | -18.90K | -4.00K | -11.20K | -12.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.72M | -1.72M | -1.72M | -1.72M | -1.72M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.74M | -1.74M | -1.73M | -1.73M | -1.73M |
| Foreign Exchange rate Adjustments | 34.00K | 22.50K | -48.90K | -17.70K | -73.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.56M | -1.42M | 893.70K | -3.68M | 3.65M |